论文部分内容阅读
莫西沙星(Moxifloxacin)是不久前上市的新型广谱抗菌药,属第四代氟喹诺酮类药物。莫西沙星上市的时间虽然不长,但在国内外市场上已显示出良好的医疗效果和较大的发展潜力,其市场前景看好。 1.应用特点莫西沙星是新一代氟喹诺酮类抗菌药物,其化学结构与其它氟喹诺酮类品种有明显不同,在其分子结构的8位碳原子上,引入了甲氧基团。
Moxifloxacin (Moxifloxacin) is a new broad-spectrum antibacterial drug marketed recently and is the fourth-generation fluoroquinolone drug. Although the time for listing moxifloxacin is not long, it has shown good medical effects and great potential for development in domestic and overseas markets and its market prospect is promising. 1. Application characteristics Moxifloxacin is a new generation of fluoroquinolone antibacterial drugs, its chemical structure and other fluoroquinolones species is significantly different, in its molecular structure of the 8 carbon atoms, the introduction of methoxy groups.